Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs

Nuclear Cardiology Unit, Heart Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel.

OBJECTIVES: This study evaluated the diagnostic value of dipyridamole plus low level treadmill exercise (dipyridamole stress) thallium-201 single-photon emission computed tomography (SPECT) in patients taking antianginal drugs. BACKGROUND: Dipyridamole stress is the major substitute for maximal exercise in patients referred for myocardial perfusion imaging. Although antianginal drugs are commonly suspended before exercise, dipyridamole stress is usually performed without discontinuing these drugs. METHODS: Twenty-six patients underwent two dipyridamole perfusion studies: the first without (SPECT-1) and the second with (SPECT-2) antianginal treatment. Twenty-one patients (81%) received calcium antagonists, 19 (73%) received nitrates, and 8 (31%) received beta-blockers. Eighteen of the patients underwent coronary angiography. Data are presented as the mean value +/- SD. RESULTS: Visual scoring yielded significantly larger and more severe reversible perfusion defects for SPECT-1 than for SPECT-2. Quantitative analysis showed larger perfusion defects on stress images of SPECT-1 in the left anterior descending coronary artery (LAD) (25 +/- 21% vs. 17 +/- 15%, p = 0.003), left circumflex coronary artery (LCx) (56 +/- 35% vs. 48 +/- 36%, p = 0.03) and right coronary artery (RCA) (36 +/- 27% vs. 25 +/- 24%, p = 0.008) territories. Individual vessel sensitivities in the LAD, LCx and RCA territories were 93%, 79% and 100% for SPECT-1 and 64%, 50% and 70% for SPECT-2, respectively. These differences were highly significant for the LAD (p = 0.004) and LCx (p = 0.00004) territories. The overall individual vessel sensitivity of SPECT-1 was significantly higher than that of SPECT-2 (92% vs. 62%, p = 0.000003). Specificity was not significantly different in SPECT-1 compared with SPECT-2 (80% and 93%, p = 0.33). CONCLUSIONS: Continued use of antianginal drugs before dipyridamole plus low level treadmill exercise thallium-201 SPECT may reduce the extent and severity of myocardial perfusion defects, resulting in underestimation of coronary artery disease.

This article has been cited by other articles:

				E. Reyes, J. Stirrup, M. Roughton, S. D'Souza, S. R. Underwood, and C. Anagnostopoulos Attenuation of Adenosine-Induced Myocardial Perfusion Heterogeneity by Atenolol and Other Cardioselective {beta}-Adrenoceptor Blockers: A Crossover Myocardial Perfusion Imaging Study J. Nucl. Med., July 1, 2010; 51(7): 1036 - 1043. [Abstract] [Full Text] [PDF]

				R. C. Pullatt, D. I. Silverman, and G. V. Heller Are Long-Term Outcomes of Medium- to High-Risk Patients Undergoing Vascular Surgery Affected by the Ischemia Evaluation Strategy? J. Am. Coll. Cardiol., March 30, 2010; 55(13): 1397 - 1398. [Full Text] [PDF]

				G. J. Zoghbi, T. A. Dorfman, and A. E. Iskandrian The Effects of Medications on Myocardial Perfusion J. Am. Coll. Cardiol., August 5, 2008; 52(6): 401 - 416. [Abstract] [Full Text] [PDF]

				M. D. Cerqueira, P. Nguyen, P. Staehr, S. R. Underwood, A. E. Iskandrian, and on behalf of the ADVANCE-MPI Trial Investigators Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 307 - 316. [Abstract] [Full Text] [PDF]

				C Y Loong and C Anagnostopoulos Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging Heart, August 1, 2004; 90(suppl_5): v2 - v9. [Full Text] [PDF]

				R. Taillefer, A. W. Ahlberg, Y. Masood, C. M. White, I. Lamargese, J. F. Mather, C. C. McGill, and G. V. Heller Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1475 - 1483. [Abstract] [Full Text] [PDF]

				M. C. Gerson Reduction in dipyridamole-induced single-photon emission computed tomography myocardial defect size by beta-blockers: Time to re-examine the patient preparation protocol for pharmacologic stress testing J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1484 - 1486. [Full Text] [PDF]

				J. Auer, R. Berent, B. Eber, R. A. O'Rourke, T. Chaudhuri, L. Shaw, and D. S. Berman Anti-Ischemic Therapy and Myocardial Ischemia Shown by Single Photon Emission Computed Tomography Imaging Circulation, December 11, 2001; 104(24): e151 - e152. [Full Text] [PDF]